‘We need it now’: U.S. farm country pins hopes on China trade deal
March 6, 2019
Czech cyber watchdog says its Huawei warning took U.S. by surprise
March 6, 2019

Bristol-Myers tells opponents Celgene deal is ‘best path’

Bristol-Myers Squibb urged shareholders on Wednesday to support its planned $74 billion takeover of Celgene Corp, as it faces opposition from two large investors to what could be the largest pharmaceutical deal ever.

Powered by WPeMatico